Notification of Shareholding
April 10 2008 - 4:26AM
UK Regulatory
RNS Number:0544S
Arana Therapeutics Limited
10 April 2008
For Immediate Release 10 April 2008
Arana Therapeutics Limited
Notification of Shareholding
Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer advises that on 10 April 2008 Lim Sen Yap has advised the
Australian Securities Exchange (www.asx.com.au) (ASX) that himself and his
associates (as defined under the Corporations Act 2001 (Australia)) held a total
of 27,378,853 ordinary shares in the Company (11.65% of the issued share capital
of the Company) as at 4 April 2008, compared with 24,984,089 ordinary shares of
the Company (10.63% of the issued share capital of the Company) advised to the
ASX on 26 February 2008. A copy of the notice filed by Lim Sen Yap today is
attached.
For further information, please contact:
Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer +61 (0)2 8061 9900
Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich +44 (0)20 7466 5000
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGCGDSUDBGGIG
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From May 2024 to Jun 2024
Arana Therap. (LSE:AAHX)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Arana Therap. (London Stock Exchange): 0 recent articles
More Arana Therapeutics News Articles